Demographic characteristics:
Out of the 600 participants, 61.3% were male and 38.7% were female. 10% of the staff was in the university, and most of the students were from 32% College of Human Medicine, 14.7% College of Dentistry and 12.7% from College of Computer Engineering respectively. Most of them were in their second year of study 24.7%. Most of the participants were single. (Table. 1)
Questions about the COVID-19 vaccine:
Most of the participants took the vaccine with its complete program consisting of two doses by 39.3%, and 25.3% of them took the vaccine with its complete program consisting of one dose, while 19.3% of the participants received the first dose of the vaccine without the second, and only 16% received the booster dose.
42.7% stated that they had contracted the Corona virus before receiving the vaccine, compared to 57.3% who were not infected. While 16.7% reported that they were infected with the Corona virus after receiving the vaccine, compared to 83.3% who were not infected.
Most of the participants received Sinopharm (Chinese)/Sinovac (Chinese) 27.3%, and AstraZeneca (British) 27.3%. And 17.3% received the Sputnik v / Sputnik Lite (Russian) vaccine, 16% of them received the Pfizer (American) vaccine, 8% received Johnson / Johnson (the American), and only 4% received the Moderna vaccine.
56% of the participants believed that they had side effects after receiving a dose of the corona vaccine. Most of these symptoms appeared within 9 to 12 hours 30.7%, and most of them lasted from one to three days 35.5%.
Most of the participants assessed the side effects associated with the vaccine as mild, with 38.7%, 25.3% assessed the side effects as moderate, and only 4.7% had severe side effects. (Table.2)
Side effects of covid 19 vaccines:
Participants reported experiencing several side effects, depending on the dose they received:
After receiving the first dose, participants reported suffering from pain, swelling and redness at the injection site (49.3%), headache (51.3%), high fever and chills (40%), malaise and fatigue (48.7%), and pain in joints and muscles (43.3%). Dizziness (18%), sweating (26%), stuffy and runny nose (22%), chest pain and shortness of breath (16.7%), coughing (14.7%), nausea and vomiting (14%), sore throat (14.7%) Abdominal pain (14%), diarrhea or constipation (10%), bruising (4.7%), eye pain or dry eyes (3.3%), swelling in the ankles and feet (4.7%), and sleep disturbances (9.3%), arrhythmias (7.3%), and anaphylactic shock (3.3%).
After receiving the second dose, participants experienced rash (6.7%), swelling of the lips, eyes, and tongue (5.3%), memory disturbances (4.7%), depression (6%), and itching (4%).
Finally, after receiving the booster dose, participants experienced ocular pain or dry eyes (3.3%), a tendency to bleed (epistaxis or bleeding from the gums) (3.3%), and memory disturbances (4.7%).
(Table. 3)
Study of the relationship between receiving the Covid 19 vaccine and study variables
When studying the relationship between receiving the Covid 19 vaccine and infection with the Corona virus before receiving the vaccine, the results showed a statistically significant relationship between them. (p < 0.001)
When studying the relationship between receiving the Covid 19 vaccine and infection with the Corona virus after receiving the vaccine, the results showed a statistically significant relationship between them. Most of those who took one dose of the two-dose vaccine without the second dose (24.1%) contracted a virus after receiving the vaccine. (p < 0.05)
When studying the relationship between receiving the Covid 19 vaccine and receiving the influenza vaccine this year, the results showed a statistically significant relationship between them. Most of those who received the vaccine with its full program of two doses (23.7%) received the influenza vaccine this year. (p < 0.05)
When examining the relationship between receiving the Covid 19 vaccine and the type of vaccine, the results showed a statistically significant relationship between them. Most of those who took one dose of the two-dose vaccine without the second dose received Sinopharma / Sinovac (48.3%). (p < 0.001)
When studying the relationship between receiving the Covid 19 vaccine and whether side effects appeared after receiving the vaccine, the results showed a statistically significant relationship between them. Most of those who took the single-dose vaccine (76.3%) experienced more prominent side effects. (p < 0.001)
When studying the relationship between receiving the Covid-19 vaccine and the severity of side effects, the results showed a statistically significant relationship between them. Most of those who received the single-dose vaccine (52.6%) evaluated their side effects as mild. (p < 0.001)
The relationship between receiving the COVID-19 vaccine and the side effects associated with the vaccine
When studying the relationship between whether you took the Covid 19 vaccine and the side effects of the vaccine, the results showed a statistically significant relationship between them. The most prominent side effects associated with the vaccine were as follows:
Most of those who received one dose of Covid vaccine without the second dose experienced significant pain, swelling and redness at the injection site (72.4%), headache (82.8%), and high fever and chills (69%). At the same time, depression (93.1%), sleep disturbances (89.7%), swelling of the lips, eyes, and tongue (96.6%), and anaphylactic shock (96.6%) were no greater than the rest of the participants. (p < 0.05)
Most of those who received the COVID-19 vaccine with the booster dose significantly experienced malaise and fatigue (75%), and joint and muscle pain (70.8%). (p < 0.05)
Most of those who received the single dose COVID-19 vaccine did not significantly experience dizziness (92.1%), sweating (76.3%), stuffy and runny nose (89.5%), chest pain or shortness of breath (81.6%), and cough (94.7%). ), nausea and vomiting (89.5%), sore throat (81.6%), abdominal pain (84.2%), diarrhea or constipation (92.1%), body bruising (94.7%), skin rashes (92.1%), and ocular or Eye dryness (100%), bleeding tendency (epistaxis or bleeding from the gums) (97.4%), swelling in the ankles and feet (97.4%), memory disturbances (97.4%), and skin itching (94.7%). (p < 0.05)